rs104893741

Variant summary

Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PVS1PS3PM2PP5_Very_Strong

The NM_023067.4(FOXL2):​c.655C>T​(p.Gln219*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005417057: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."".

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

FOXL2
NM_023067.4 stop_gained

Scores

6
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 5.15

Publications

9 publications found
Variant links:
Genes affected
FOXL2 (HGNC:1092): (forkhead box L2) This gene encodes a forkhead transcription factor. The protein contains a fork-head DNA-binding domain and may play a role in ovarian development and function. Expansion of a polyalanine repeat region and other mutations in this gene are a cause of blepharophimosis syndrome and premature ovarian failure 3. [provided by RefSeq, Jul 2016]
FOXL2 Gene-Disease associations (from GenCC):
  • blepharophimosis, ptosis, and epicanthus inversus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • premature ovarian failure 3
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_023067.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 22 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 75 pathogenic variants in the truncated region.
PS3
PS3 evidence extracted from ClinVar submissions: SCV005417057: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-138946068-G-A is Pathogenic according to our data. Variant chr3-138946068-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 4853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_023067.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXL2
NM_023067.4
MANE Select
c.655C>Tp.Gln219*
stop_gained
Exon 1 of 1NP_075555.1Q53ZD3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXL2
ENST00000648323.1
MANE Select
c.655C>Tp.Gln219*
stop_gained
Exon 1 of 1ENSP00000497217.1P58012

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1265594
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
622124
African (AFR)
AF:
0.00
AC:
0
AN:
24180
American (AMR)
AF:
0.00
AC:
0
AN:
13104
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
63272
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31828
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3718
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1028814
Other (OTH)
AF:
0.00
AC:
0
AN:
52064
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Blepharophimosis, ptosis, and epicanthus inversus syndrome (2)
1
-
-
Blepharophimosis, ptosis, and epicanthus inversus syndrome;C1837008:Premature ovarian failure 3 (1)
1
-
-
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I (1)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
39
DANN
Uncertain
1.0
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.98
D
PhyloP100
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs104893741;
hg19: chr3-138664910;
COSMIC: COSV57730563;
COSMIC: COSV57730563;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.